Qing Min Selected Research

secretory IgM

1/2020

Regulation of Humoral Immune Responses and B Cell Tolerance by the IgM Fc Receptor (FcμR).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qing Min Research Topics

Disease

2	Vascular Calcification 01/2021 - 01/2020
2	Peripheral Nerve Injuries 01/2021 - 01/2019
2	Colitis 01/2019 - 02/2009
2	Inflammation (Inflammations) 01/2019 - 01/2017
2	Neoplasms (Cancer) 01/2019 - 01/2017
2	Obesity 01/2019 - 09/2014
1	Lymphopenia (Lymphocytopenia) 10/2021
1	Infections 01/2020
1	Deficiency of Alpha Interleukin 2 Receptor 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Vascular Diseases (Vascular Disease) 01/2019
1	Abdominal Aortic Aneurysm 01/2019
1	Hypertrophy 01/2019
1	Cardiomyopathies (Cardiomyopathy) 01/2017
1	Diabetes Mellitus 01/2017
1	Cardiotoxicity 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Insulin Resistance 09/2014
1	Metabolic Diseases (Metabolic Disease) 09/2014
1	Tuberous Sclerosis 2 09/2014
1	Type 2 Diabetes Mellitus (MODY) 09/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2010
1	Infarction (Infarctions) 01/2006
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2006
1	Brain Ischemia (Cerebral Ischemia) 01/2006
1	Reperfusion Injury 01/2006
1	Edema (Dropsy) 01/2006

Drug/Important Bio-Agent (IBA)

2	AutoantibodiesIBA 10/2021 - 01/2020
2	Immunoglobulin G (IgG)IBA 10/2021 - 01/2020
2	HMGB1 Protein (HMG1)IBA 01/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2019 - 02/2009
1	Immunoglobulin M (IgM)IBA 10/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 01/2021
1	secretory IgMIBA 01/2020
1	AntigensIBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	VitaminsIBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	Angiotensin IIIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2019
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2019
1	Lipase (Acid Lipase)FDA Link 01/2019
1	NeuropeptidesIBA 01/2019
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Blood Glucose (Blood Sugar)IBA 01/2017
1	FlavonoidsIBA 01/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 09/2014
1	Glucose (Dextrose)FDA LinkGeneric 09/2014
1	LipidsIBA 09/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2010
1	PPAR gammaIBA 02/2010
1	OxazoloneIBA 02/2009
1	sym-trinitrobenzeneIBA 02/2009
1	Sulfonic AcidsIBA 02/2009
1	PectinsIBA 02/2009
1	EnzymesIBA 01/2006
1	theaflavinIBA 01/2006
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2006

Therapy/Procedure

1	Oral Administration 01/2019
1	Drug Therapy (Chemotherapy) 01/2017